Ian R. Wilding

4.1k total citations
88 papers, 3.2k citations indexed

About

Ian R. Wilding is a scholar working on Pharmaceutical Science, Gastroenterology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ian R. Wilding has authored 88 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmaceutical Science, 27 papers in Gastroenterology and 19 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ian R. Wilding's work include Drug Solubulity and Delivery Systems (35 papers), Gastrointestinal motility and disorders (18 papers) and Advanced Drug Delivery Systems (17 papers). Ian R. Wilding is often cited by papers focused on Drug Solubulity and Delivery Systems (35 papers), Gastrointestinal motility and disorders (18 papers) and Advanced Drug Delivery Systems (17 papers). Ian R. Wilding collaborates with scholars based in United Kingdom, United States and Japan. Ian R. Wilding's co-authors include S.S. Davis, Alyson Connor, Alastair Coupe, Stanley S. Davis, Robert A. Sparrow, Peter H. Hirst, John G. Hardy, Ewart T. Cole, Stephen P. Newman and Stanton Newman and has published in prestigious journals such as Applied Physics Letters, Advanced Drug Delivery Reviews and The FASEB Journal.

In The Last Decade

Ian R. Wilding

88 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian R. Wilding United Kingdom	33	1.6k	782	481	385	363	88	3.2k
David Fleisher United States	26	1.1k 0.7×	399 0.5×	283 0.6×	419 1.1×	944 2.6×	59	3.1k
Jeffrey L. Barnett United States	34	579 0.4×	1.2k 1.6×	1.6k 3.4×	214 0.6×	767 2.1×	71	4.1k
Kanji Takada Japan	39	2.7k 1.6×	207 0.3×	278 0.6×	404 1.0×	698 1.9×	246	5.1k
Stanley S. Davis United Kingdom	38	2.0k 1.3×	294 0.4×	232 0.5×	245 0.6×	316 0.9×	81	4.3k
Marie Cecilie Paasche Roland Norway	26	565 0.4×	200 0.3×	491 1.0×	586 1.5×	245 0.7×	102	2.9k
Joachim Brouwers Belgium	39	3.6k 2.2×	485 0.6×	177 0.4×	506 1.3×	860 2.4×	110	5.2k
Kazutaka Higaki Japan	37	2.0k 1.2×	110 0.1×	287 0.6×	285 0.7×	756 2.1×	167	5.0k
Werner Siegmund Germany	42	910 0.6×	413 0.5×	613 1.3×	1.5k 4.0×	2.7k 7.4×	185	6.3k
Caroline L. Hoad United Kingdom	32	398 0.2×	1.7k 2.1×	926 1.9×	86 0.2×	191 0.5×	130	3.7k
Lenard M. Lichtenberger United States	43	344 0.2×	764 1.0×	2.0k 4.2×	171 0.4×	680 1.9×	160	5.8k

Countries citing papers authored by Ian R. Wilding

Since Specialization

Citations

This map shows the geographic impact of Ian R. Wilding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Wilding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Wilding more than expected).

Fields of papers citing papers by Ian R. Wilding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Wilding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Wilding. The network helps show where Ian R. Wilding may publish in the future.

Co-authorship network of co-authors of Ian R. Wilding

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Wilding. A scholar is included among the top collaborators of Ian R. Wilding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Wilding. Ian R. Wilding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thombre, Avinash G., Sheri L. Shamblin, Bimal Malhotra, et al.. (2015). Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone. Journal of Controlled Release. 213. 10–17. 11 indexed citations

Macha, Sreeraj, et al.. (2009). Assessment of Nevirapine Bioavailability From Targeted Sites in the Human Gastrointestinal Tract. The Journal of Clinical Pharmacology. 49(12). 1417–1425. 13 indexed citations

Linnebjerg, Helle, Soomin Park, Prajakti A. Kothare, et al.. (2008). Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regulatory Peptides. 151(1-3). 123–129. 207 indexed citations

Cole, Ewart T., Robert A. Scott, Dominique Cadé, Alyson Connor, & Ian R. Wilding. (2004). In Vitro and in Vivo Pharmacoscintigraphic Evaluation of Ibuprofen Hypromellose and Gelatin Capsules. Pharmaceutical Research. 21(5). 793–798. 50 indexed citations

Goto, Takeshi, et al.. (2004). Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans. Journal of Controlled Release. 97(1). 31–42. 28 indexed citations

Newman, Stephen P., Peter H. Hirst, & Ian R. Wilding. (2003). New developments in radionuclide imaging for assessing drug delivery in man. European Journal of Pharmaceutical Sciences. 18(1). 19–22. 18 indexed citations

Wilding, Ian R.. (2002). Bioequivalence Testing for Locally Acting Gastrointestinal Products: What Role for Gamma Scintigraphy?. The Journal of Clinical Pharmacology. 42(11). 1200–1210. 11 indexed citations

Cole, Ewart T., Robert A. Scott, Alyson Connor, et al.. (2002). Enteric coated HPMC capsules designed to achieve intestinal targeting. International Journal of Pharmaceutics. 231(1). 83–95. 180 indexed citations

Davis, Stanley S., et al.. (2002). The effect of ileal brake activators on the oral bioavailability of atenolol in man. International Journal of Pharmaceutics. 248(1-2). 61–70. 16 indexed citations

10.

Wilding, Ian R.. (2000). Site-Specific Drug Delivery in the Gastrointestinal Tract. Critical Reviews in Therapeutic Drug Carrier Systems. 17(6). 76–76. 56 indexed citations

11.

Wilding, Ian R. & Donald Heald. (1999). Visualization of Product Performance in the Gut: What Role in the Drug Development/Regulatory Paradigm?. The Journal of Clinical Pharmacology. 39(S1). 6S–9S. 1 indexed citations

12.

Wilding, Ian R., C.J. Kenyon, G. Hooper, et al.. (1995). Colonic spreading of a non‐chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis. Alimentary Pharmacology & Therapeutics. 9(2). 161–166. 14 indexed citations

13.

Wilding, Ian R., S.S. Davis, & Derek T. O’Hagan. (1994). Optimizing gastrointestinal delivery of drugs. Baillière s Clinical Gastroenterology. 8(2). 255–270. 6 indexed citations

14.

Awang, Mohamed, John G. Hardy, S.S. Davis, et al.. (1994). Evaluation of 153Sm-diethylenetriaminepentaacetic acid for radiolabelling of pharmaceutical dosage forms by neutron activation. Nuclear Medicine and Biology. 21(7). 905–909. 4 indexed citations

15.

Davis, S.S., et al.. (1993). Gastrointestinal transit of a matrix tablet formulation: comparison of canine and human data. International Journal of Pharmaceutics. 94(1-3). 235–238. 46 indexed citations

16.

Wilding, Ian R., et al.. (1992). In Vivo Evaluation of Enteric-Coated Naproxen Tablets Using Gamma Scintigraphy. Pharmaceutical Research. 9(11). 1436–1441. 55 indexed citations

17.

Coupe, Alastair, Stanley S. Davis, David F. Evans, & Ian R. Wilding. (1992). Nocturnal scintigraphic imaging to investigate the gastrointestinal transit of dosage forms. Journal of Controlled Release. 20(2). 155–162. 24 indexed citations

18.

Wilding, Ian R., J G Hardy, S.S. Davis, et al.. (1991). Characterisation of the In Vivo Behaviour of a Controlled-Release Formulation of Levodopa (Sinemet CR). Clinical Neuropharmacology. 14(4). 305–321. 36 indexed citations

19.

Coupe, Alastair, Stanley S. Davis, David F. Evans, & Ian R. Wilding. (1991). Correlation of the Gastric Emptying of Nondisintegrating Tablets with Gastrointestinal Motility. Pharmaceutical Research. 8(10). 1281–1285. 73 indexed citations

20.

Melia, Colin D., et al.. (1991). A Simple and Rapid Method for the Quantification of Eudragit RS100 and RL100 Poly(methacrylates) in Sustained-Release Dosage Forms. Pharmaceutical Research. 8(7). 899–902. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact